The Moores Cancer Center at UC San Diego Health is revamping its clinical trials right as its director is stepping down for personal reasons, the La Jolla Light reported June 7.
The Latest
Cancer survivors in the United States who report diminished quality of life "more than doubled" in the past two decades, according to a study published May 11 in JAMA Oncology.
Tampa-based Moffitt Cancer Center appointed Xavier Avat as chief business officer, the Business Observer reported June 5.
Continuing immunotherapy treatments when a renal cancer patient's disease has progressed may actually do more harm than good, according to results of a new study from Los Angeles-based City of Hope researchers.
Some patients with locally advanced rectal cancer may be able to safely forgo radiation before surgery to remove tumors, according to research published June 4 in The New England Journal of Medicine and the Journal of Clinical Oncology.
Grail, a company that developed blood tests to detect cancer, mistakenly sent approximately 400 customers letters saying they might be positive for the disease, The New York Times reported June 4.
GenesisCare, a global cancer and cardiac care service provider, has filed for Chapter 11 bankruptcy, according to a June 1 press release.
Here are the 10 most-read oncology stories published by Becker's in May:
Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.